Publicaties

de Veer  RC, van Hooff MC, Corpechot  C, Thorburn  D, Invernizzi  P, Lammers WJ, Janssen  HLA, Battezzati PM, Nevens  F, Lindor KD, Floreani  A, Ponsioen CY, Mayo MJ, Parés A, Mason AL, Kowdley  KV, Trivedi PJ, Hirschfield GM, Goet JC, Bruns T, Dalekos  GN, Gatselis  NK, Verhelst X, Hansen  BE, Harms  MH, van der Meer AJ.
Ursodeoxycholic acid treatment-induced GLOBE score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis. American Journal of Gastroenterology. 2022 Dec 8. Online ahead of print.
PMID: 36621963
DOI: 10.14309/ajg.0000000000002128

de Veer  RC, Harms  MH, Corpechot  C, Thorburn  D, Invernizzi  P, Janssen  HLA, Battezzati PM, Nevens  F, Lindor KD, Floreani  A, Ponsioen CY, Mayo MJ, Parés A, Mason AL, Kowdley  KV, Trivedi PJ, Hirschfield GM, Bruns T, Dalekos  GN, Gatselis  NK, Verhelst  X, Lammers WJ, Hansen  BE, van Buuren HR, van der Meer AJ. Global PBC Study Group.
Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid. Alimentary Pharmacology & Therapeutics. 2022 Nov;56(9):1408-1418.
PMID: 36138566
DOI: 10.1111/apt.17226

Herta T, Kersten R, Chang JC, Hubers L, Go S, Tolernaars D, Paulusma C, Nathanson M, Oude Elferink RPJ, van de Graaf KFJ, Beuers U.
Role of the IgG4-related cholangitis autoantigen annexin A11 in cholangiocyte protection. Journal of Hepatology. 2022 Feb;76(2):319-331.
PMID: 34718050
DOI: 10.1016/j.jhep.2021.10.009

Hubers L, Schuurman AR, Buijs J, Mostafavi N, Bruno MJ, Vermeulen RCH, Huss A, van Buuren HR, Beuers U.
Blue-collar work is a risk factor for developing IgG4-related disease of the biliary tract and pancreas. Journal of Hepatology Reports. 2021 Oct 9;3(6):100385.
PMID: 34816110
DOI: 10.1016/j.jhepr.2021.100385

de Vries E, Bolier R, Goet J, Parés A, Verbeek J, de Vree M, Drenth J, van Erpecum K, van Nieuwkerk K, van der Heide F, Mostafavi N, Helder J, Ponsioen C, Oude Elferink RPJ, van Buuren H, Beuers U. Netherlands Association for the Study of the Liver – Cholestasis Working Group.
Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial. Gastroenterology. 2021 Feb;160(3):734-743.e6.
PMID: 33031833
DOI: 10.1053/j.gastro.2020.10.001

de Vries E, Mazzetti M, Takkenberg B, Mostafavi N, Bikker H, Marzioni M, de Veer R, van der Meer A, Doukas M, Verheij J, Beuers U.
Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma. Liver International. 2020 Dec;40(12):3042-3050.
PMID: 32893960
DOI: 10.1111/liv.14662

Harms MH, de Veer RC, Lammers WJ, Corpechot C, Thorburn D, Janssen HLA, Lindor KD, Trivedi PJ, Hirschfield GM, Pares A, Floreani A, Mayo MJ, Invernizzi P, Battezzati PM, Nevens F, Ponsioen CY, Mason AL, Kowdley KV, Hansen BE, Buuren HRV, van der Meer AJ.
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis. Gut. 2020 Aug;69(8):1502-1509.
PMID: 31843787
DOI: 10.1136/gutjnl-2019-319057

Harms MH, van Buuren HR, Corpechot C, Thorburn D, Janssen HLA, Lindor KD, Hirschfield GM, Parés A, Floreani A, Mayo MJ, Invernizzi P, Battezzati PM, Nevens F, Ponsioen CY, Mason AL, Kowdley KV, Lammers WJ, Hansen BE, van der Meer AJ.
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis. Journal of Hepatology. 2019 Aug;71(2):357-365.
PMID: 30980847
DOI: 10.1016/j.jhep.2019.04.001

Hubers L, Vos H, Schuurman AR, Erken R, Oude Elferink RPJ, Burgering B, van de Graaf KFJ, Beuers U.
Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease. Gut. 2018 Apr;67(4):728-735.
PMID: 28765476
DOI: 10.1136/gutjnl-2017-314548